Nadine Abi-Jaoudeh, MD

Dr Abi-Jaoudeh

Chemoembolization 101

Nadine Abi-Jaoudeh , MD;

01/28/2022

HCC Panel: What Else Happened

Nima Kokabi , MD;

Edward S. Kim , MD, FACP, MBA;

Nadine Abi-Jaoudeh , MD;

Michael Chuong , MD;

Karen T. Brown , MD, FSIR;

02/04/2022

Practical Approach to Liver Disease: Multidisciplinary Tumor Board

Horacio Asbun , MD;

Santiago Aparo , MD, MS;

Fernando de Zarraga , MD;

Karen T. Brown , MD, FSIR;

Edward S. Kim , MD, FACP, MBA;

Michael Chuong , MD;

Raul N. Uppot , MD;

Nadine Abi-Jaoudeh , MD;

Nora Tabori , MD;

02/04/2022

Where Does IO Stand in the NCCN Guidelines: Renal Cell Carcinoma

Nadine Abi-Jaoudeh , MD;

02/16/2022

Where Does IO Stand in the NCCN Guidelines: Panel Discussion

Nima Kokabi , MD;

Ahmed K. Abdel Aal , MD, PhD;

Nicholas Fidelman , MD;

Alda L. Tam , MD, FRCPC, MBA;

Nadine Abi-Jaoudeh , MD;

Daniel B. Brown , MD, FSIR;

02/16/2022

Mets Panel: What Else Happened

William S. Rilling , MD, FSIR;

Nadine Abi-Jaoudeh , MD;

Horacio Asbun , MD;

Fernando de Zarraga , MD;

11/13/2019

IO Take-Home Points from SIR 2019

Nadine Abi-Jaoudeh , MD;

11/13/2019

Cone Beam CT: How I Do it

Nadine Abi-Jaoudeh , MD;

11/12/2019

Interview

Interventional Oncology Year in Review

03/17/2017

Nadine Abi-Jaoudeh , MD;

This past year has been marked by the completion of some long-awaited studies that led to a number of surprises. In February 2016, Dr Brown’s prospective, randomized study comparing doxorubicin-loaded beads vs bland beads for hepatocellular...

This past year has been marked by the completion of some long-awaited studies that led to a number of surprises. In February 2016, Dr Brown’s prospective, randomized study comparing doxorubicin-loaded beads vs bland beads for hepatocellular...

This past year has been marked...

03/17/2017

IO Learning

HCC: Year in Review

01 Abi-Jaoudeh_Nadine Oct 6 CIO2020 FINAL from HMP on Vimeo.

Nadine Abi-Jaoudeh , MD;

07/26/2021

Featured CME Course

Targeted Therapies for the Management of Chronic Lymphocytic Leukemia: Evaluating the Evidence to Optimize Patient Care and Outcomes

Upcoming Events

February 2 ⁠–⁠ February 5

February 7 ⁠–⁠ February 9

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

March 22 ⁠–⁠ March 23

NP Institute

March 27 ⁠–⁠ March 30

March 31 ⁠–⁠ April 2

April 21 ⁠–⁠ April 24

April 30 ⁠–⁠ May 4

WoundCon

May 1 ⁠–⁠ May 3

See Full Calendar